ResearcherPeking UniversityActive in the last 2 years
Ying Zhao
Matched on ORCID iD 0000-0003-3995-0639; OpenAlex author ID A5028295358. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 4
- CAFs shape the immunosuppressive microenvironment of pancreatic cancer through the Lin28b-STING Axis. Last author DOI 10.1038/s41467-026-76495-3↗
- KRAS Inhibitor Resistance Confers a Targetable Vulnerability to Ferroptosis in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/0008-5472.can-26-1490↗
- UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis. Last author DOI 10.1016/j.celrep.2024.113808↗
- Autophagy in pancreatic cancer. First author DOI 10.1093/jmcb/mjab053↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sihan Huo · 3 shared papers, 2024–2026 · strength 0.74
- Paper CAFs shape the immunosuppressive microenvironment of pancreatic cancer through the Lin28b-STING Axis. DOI 10.1038/s41467-026-76495-3↗
- Paper KRAS Inhibitor Resistance Confers a Targetable Vulnerability to Ferroptosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-26-1490↗
- Paper UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis. DOI 10.1016/j.celrep.2024.113808↗
- Minghe Fan · 3 shared papers, 2024–2026 · strength 0.74
- Paper CAFs shape the immunosuppressive microenvironment of pancreatic cancer through the Lin28b-STING Axis. DOI 10.1038/s41467-026-76495-3↗
- Paper KRAS Inhibitor Resistance Confers a Targetable Vulnerability to Ferroptosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-26-1490↗
- Paper UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis. DOI 10.1016/j.celrep.2024.113808↗
- Congting Guo · 1 shared paper, 2022 · strength 0.33
- Jingfeng Tang · 1 shared paper, 2026 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.